Ernexa Therapeutics Inc. (ERNA) Financials
ERNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 6.3 million | 3.1 million |
| March 31, 2026 | 10.5 million | 3.7 million |
| Dec. 31, 2025 | 5.8 million | 3.4 million |
| Sept. 30, 2025 | 6.2 million | 2.6 million |
ERNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -4.2 million | 320000 |
| March 31, 2026 | -2.3 million | 309000 |
| Dec. 31, 2025 | -1.2 million | 333000 |
| Sept. 30, 2025 | -1.3 million | 293000 |
ERNA Net Income
No data available :(
ERNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 5.0 million | - | 349000 |
| March 31, 2026 | 9.2 million | - | 226000 |
| Dec. 31, 2025 | 1.9 million | - | 277000 |
| Sept. 30, 2025 | 3.0 million | - | 552000 |
ERNA Shares Outstanding
ERNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3000 | 2.8 million | 1.3 million | - |
| March 31, 2026 | 2000 | 1.9 million | 1.6 million | - |
| Dec. 31, 2025 | 15000 | 676000 | 1.4 million | - |
| Sept. 30, 2025 | 22000 | 1.0 million | 958000 | 6000 |
ERNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 86000 |
| Dec. 31, 2025 | - | 69000 |
| Sept. 30, 2025 | - | - |
ERNA
Price: $4.86
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.0 million